Detalles de la búsqueda
1.
Patient Navigation in Cancer Treatment: A Systematic Review.
Curr Oncol Rep
; 26(5): 504-537, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581470
2.
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes.
Oncologist
; 28(10): 901-910, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120291
3.
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer.
J Natl Compr Canc Netw
; 21(7): 705-714.e17, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37433439
4.
5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis.
J Urol
; 207(1): 183-189, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433301
5.
Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
BMC Cancer
; 22(1): 476, 2022 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35490227
6.
Opioid Prescription Trends in a US Dental School Clinic, 2014-2018: A Retrospective Study Using Electronic Health Record Data.
J Public Health Manag Pract
; 28(1): E264-E272, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-33729192
7.
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
Int J Cancer
; 148(1): 99-105, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32930425
8.
Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
Radiology
; 299(3): 613-623, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33847515
9.
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.
J Urol
; 206(3): 623-629, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003011
10.
A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy.
J Urol
; 205(2): 420-425, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32945736
11.
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
J Urol
; 205(4): 1047-1054, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33493001
12.
Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS).
J Urol
; 206(3): 613-622, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872049
13.
Culturally competent communication in Indigenous disability assessment: a qualitative study.
Int J Equity Health
; 20(1): 68, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648504
14.
Cardiovascular Toxicities of Androgen Deprivation Therapy.
Curr Treat Options Oncol
; 22(6): 47, 2021 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33866442
15.
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.
J Transl Med
; 18(1): 10, 2020 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31910880
16.
Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010.
Cancer Causes Control
; 30(6): 627-635, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30997591
17.
Impact of Subsequent Biopsies on Comprehensive Health Related Quality of Life in Patients with and without Prostate Cancer.
J Urol
; 201(5): 916-922, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30676475
18.
A Cross-Sectional Analysis of the Lung Cancer Screening Eligibility Among Cancer Survivors Who Ever Smoked.
J Gen Intern Med
; 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321314
19.
Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective.
J Am Acad Dermatol
; 90(1): 147-150, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666421
20.
A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.
Can J Urol
; 26(4): 9809-9820, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31469635